StockData
Zura Bio Ltd logo

Zura Bio Ltd (ZURA) stock

ZURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 5/30
$0.97−0.07 (-6.75%)

Close on Nov 18, 2026Market cap $92.96MP/E –Yield –

Zura Bio r&d expenses

Research and development expenses are spending on new products and technology.

Zura Bio's R&D Expenses for the twelve months ending Sep 30, 2026 was $65.90M, up 63.3% year over year. For fiscal 2025 it was $42.08M, up 72.5% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$42.08M+72.5%
FY2024Dec 31, 2024$24.40M-44.5%
FY2023Dec 31, 2023$44.00M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$19.49M+63.1%
Q2 FY2026Jun 30, 2026$20.71M+137.9%
Q1 FY2026Mar 31, 2026$14.75M+40.8%
Q4 FY2025Dec 31, 2025$10.96M+18.6%
Q3 FY2025Sep 30, 2025$11.95M+98.2%
Q2 FY2025Jun 30, 2025$8.70M+57.1%
Q1 FY2025Mar 31, 2025$10.47M+191.5%
Q4 FY2024Dec 31, 2024$9.24M+33.5%
Q3 FY2024Sep 30, 2024$6.03M+52.1%
Q2 FY2024Jun 30, 2024$5.54M-80.4%
Q1 FY2024Mar 31, 2024$3.59M-26.4%
Q4 FY2023Dec 31, 2023$6.92M+1567.5%
Q3 FY2023Sep 30, 2023$3.97M+4564.7%
Q2 FY2023Jun 30, 2023$28.23M–
Q1 FY2023Mar 31, 2023$4.88M–
Q3 FY2022Sep 30, 2022$415.00K–
Q2 FY2022Jun 30, 2022$85.00K–

More Zura Bio figures

See a number that looks wrong?